Identifying potential drugs for treating Cardiovascular-kidney metabolic syndrome via reverse network pharmacology
BackgroundCardiovascular, Kidney and metabolic syndrome (CKM) is a complex disease, for which current therapeutic approaches have limited efficacy. This study aims to screen for potential targets and novel drugs for treating CKM using network pharmacology.MethodsUsing reverse network pharmacology, c...
Saved in:
Main Authors: | Si’ao Wen, Ao’ni Fu, Fen Liu, Yayu You, Linkai Li, Wen Xiao, Haoran Zhong, Xiuqin Hong, Xin Zhong, Yongjun Hu, Zhengyu Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-06-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1627236/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Correction: Adverse effects of finerenone in patients with heart failure: a systematic review and meta-analysis
by: Wanqian Yu, et al.
Published: (2025-07-01) -
Adverse effects of finerenone in patients with heart failure: a systematic review and meta-analysis
by: Wanqian Yu, et al.
Published: (2025-05-01) -
Hospitalized patients and stimulant use-associated heart failure: importance of ejection fraction and related risk factors
by: Akshat Agrawal, et al.
Published: (2025-07-01) -
The Role of Inflammation in the Pathophysiology of Heart Failure
by: Marwan Amara, et al.
Published: (2025-07-01) -
Intravenous iron in heart failure: still no prognostic impact, but questions remain
by: Ibrahim El-Battrawy, et al.
Published: (2025-08-01)